Danaparoid Pregnancy and Breastfeeding Warnings

Danaparoid is also known as: Orgaran

Danaparoid Pregnancy Warnings

One study reports on 2 successful full-term pregnancies with normal infants at birth. Cord blood from the infants revealed no anti-Xa activity, although the mothers demonstrated considerable activity. No bleeding problems were encountered. It does not appear that danaparoid crosses the placenta during the second and third trimesters. Successful danaparoid treatment of heparin-induced thrombocytopenia was reported in a 25-year-old woman pregnant with twins. She was treated with subcutaneous danaparoid until the time of delivery without adverse fetal or maternal effects.

Danaparoid has been assigned to pregnancy category B by the FDA. Animal studies at doses 6 to 8 times the normal recommended human dose have not revealed evidence of fetotoxicity. There are no controlled data in human pregnancy. Danaparoid should only be given during pregnancy when need has been clearly established.

Danaparoid Breastfeeding Warnings

There are no data on the excretion of danaparoid into human milk.

See Also...

• danaparoid Consumer Information
• Pregnancy Support Group
• FDA Pregnancy Categories
• Medicine use during Pregnancy
• Medicine use while Breastfeeding
• Safe Medications during Breastfeeding

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.